We are live on
!
Find out more
Jazz Pharmaceuticals
JAZZ
JAZZ
502 hedge funds and large institutions have $8.01B invested in Jazz Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 61 funds opening new positions, 161 increasing their positions, 201 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
448% more call options, than puts
Call options by funds: $130M | Put options by funds: $23.7M
22% more capital invested
Capital invested by funds: $6.56B → $8.01B (+$1.44B)
15% more first-time investments, than exits
New positions opened: 61 | Existing positions closed: 53
9% more funds holding in top 10
Funds holding in top 10: 11 → 12 (+1)
0% more funds holding
Funds holding: 501 → 502 (+1)
2.06% less ownership
Funds ownership: 102.22% → 100.16% (-2.1%)
20% less repeat investments, than reductions
Existing positions increased: 161 | Existing positions reduced: 201
Holders
502
Holders Change
+1
Holders Change %
+0.2%
% of All Funds
6.59%
Holding in Top 10
12
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+9.09%
% of All Funds
0.16%
New
61
Increased
161
Reduced
201
Closed
53
Calls
$130M
Puts
$23.7M
Net Calls
+$106M
Net Calls Change
+$44.6M
Top Buyers
| 1 |
GAM
Goldentree Asset Management
New York
|
+$136M |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
+$44.8M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$35.8M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$31.4M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$27.9M |
Top Sellers
| 1 |
VPC
Vestal Point Capital
New York
|
-$84M |
| 2 |
Millennium Management
New York
|
-$47.1M |
| 3 |
PL
Perpetual Ltd
Sydney, New South Wales,
Australia
|
-$34.2M |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$30M |
| 5 |
Morgan Stanley
New York
|
-$29.8M |
